Korro Bio, Inc. (KRRO)
Last updated: 2026-10-24 07:25:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Korro Bio, Inc. (KRRO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $12.02, with a market capitalization of $177.44M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.20 to $42.70. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$177.44M | |
$12.04 | |
$98.00 | |
$5.20 | |
$12.05 | |
215.74K | |
157.27K | |
-- | |
$42.70 | |
$5.20 | |
-- | |
-- |
Korro Bio, Inc. (KRRO) Latest Closing Stock Price
Korro Bio, Inc. (KRRO) last closed at $12.05 as of 2026-10-23 23:31:00, unchanged from the previous close of $12.05.
During the latest regular trading session, KRRO traded between $5.20 and $98.00, with a volume of 215.74K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Korro Bio, Inc. (KRRO) 7-Day Stock Price Change
Over the past seven days, Korro Bio, Inc. (KRRO) moved from $9.31 to $12.02, representing a gain of 29.12% ($2.71).
The stock traded between $8.36 and $12.69 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 252.82 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
KRRO 52-Week Price Position
Position in Range: 18.2%
KRRO is currently trading at $12.02, placing it 18.2% of the way from its 52-week low of $5.20 to its 52-week high of $42.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Korro Bio, Inc. (KRRO)?
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
Korro Bio, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 57 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Korro Bio, Inc. (KRRO) Stock on MEXC
Eligible investors can buy real shares of Korro Bio, Inc. (KRRO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Korro Bio, Inc. (KRRO) stock price today?
2.Is KRRO stock going up or down today?
3.What is KRRO pre-market price?
4.What is KRRO after-hours price?
5.Is KRRO stock trading now?
6.Where does KRRO sit relative to its 52-week high and low?
7.What sector is Korro Bio, Inc. in?
8.What is Korro Bio, Inc.'s market capitalization and where is it listed?
9.How is KRRO valued in terms of P/E ratio and EPS?
10.Does Korro Bio, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
KRRO Stock Calculator
Estimate the value between KRRO shares and USD.
KRRO Shares to USD
1.00 KRRO shares = 12.021 USD
Calculations are estimates based on the latest available price and are for reference only.


